Novel compounds 951: a biphenyloxypropanoic acid as CRTH2 modulator and intermediates

Details for Australian Patent Application No. 2008272690 (hide)

Owner AstraZeneca AB

Inventors Patel, Anil; Bonnert, Roger Victor; Rigby, Aaron; Luker, Timothy Jon

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008272690

PCT Pub. Number WO2009/004379

Priority 60/948,012 05.07.07 US

Filing date 1 July 2008

Wipo publication date 8 January 2009

Acceptance publication date 22 March 2012

International Classifications

C07D 295/18 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2009/004379 Priority application(s): WO2009/004379

22 March 2012 Application Accepted

  Published as AU-B-2008272690

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008272693-3-spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents

2008272685-Process for introduction of hydroxyethoxy side chain in bosentan